Literature DB >> 1433573

Diabetes mellitus impairs neurogenic and endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle.

K M Azadzoi1, I Saenz de Tejada.   

Abstract

The effect of alloxan-induced diabetes on the reactivity of corporeal nerves, endothelium and smooth muscle was studied in the New Zealand white rabbit. Fifteen rabbits were randomly divided into treated (n = 6) and control (n = 9) groups. The treated group was maintained for 6 weeks. Two control groups were studied. One control group (n = 3) was maintained for 6 weeks as littermate controls for diabetic group. The second control group (n = 6) was not maintained but was weight matched with the 6 week diabetic group. The reactivity of corpus cavernosum tissue from the diabetic animals and the control animals was studied in organ chambers. When tissue contraction was produced with phenylephrine for the study of relaxation to various stimuli, the tension induced was similar in the diabetic and the control groups. Relaxation of corpus cavernosum tissue to electrical stimulation of autonomic nerves as well as relaxation to the endothelium-dependent vasodilator acetylcholine were comparably unaffected in the weight matched and littermate control groups while significantly inhibited in the diabetic group. Treatment of the corporeal tissue with the cyclooxgenase inhibitor indomethacin enhanced the relaxation to electrical stimulation and to acetylcholine in the control and in the diabetic groups but did not improve the significant difference in relaxation between the two groups. Relaxation of corporeal tissue to endothelium-independent vasodilators, papaverine and nitroprusside was similar in the control groups and the diabetic groups. It is concluded that diabetes impairs neurogenic and endothelium-mediated relaxation of rabbit corpus cavernosum smooth muscle. These findings are comparable to those described in corpus cavernosum tissue from diabetic men, showing the validity of this experimental animal model. The mechanism for the nerve or endothelial dysfunction does not appear to involve alteration in cyclooxygenase products of arachidonate or the ability of the corporeal smooth muscle to relax via a cGMP-dependent mechanism. Since nitric oxide has been shown to act as the nonadrenergic noncholinergic neurotransmitter as well as endothelium-derived relaxing factor (EDRF) of the trabecular smooth muscle, it is possible that impairment of neurogenic and endothelium-dependent relaxation due to diabetes is mediated by alteration in the synthesis or availability of nitric oxide in corporeal tissue.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1433573     DOI: 10.1016/s0022-5347(17)36975-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  17 in total

Review 1.  Neurogenic erectile dysfunction.

Authors:  T F Lue
Journal:  Clin Auton Res       Date:  2001-10       Impact factor: 4.435

Review 2.  Regulation of tone in penile cavernous smooth muscle. Established concepts and new findings.

Authors:  K E Andersson; F Holmquist
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

3.  Selective nitrergic neurodegeneration in diabetes mellitus - a nitric oxide-dependent phenomenon.

Authors:  S Cellek; J Rodrigo; E Lobos; P Fernández; J Serrano; S Moncada
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

4.  Impairment of endothelium- and nerve-mediated relaxation responses in the cavernosal smooth muscle of experimentally diabetic rabbits: role of weight loss and duration of diabetes.

Authors:  Nihan Burul Bozkurt; Can Pekiner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-03-30       Impact factor: 3.000

5.  Impairment of nitrergic-mediated relaxation of rat isolated duodenum by experimental diabetes.

Authors:  M A Martinez-Cuesta; H Massuda; B J Whittle; S Moncada
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

6.  Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neuronal apoptosis in vitro: a new insight into selective nitrergic neuropathy in diabetes.

Authors:  S Cellek; W Qu; A M Schmidt; S Moncada
Journal:  Diabetologia       Date:  2003-12-16       Impact factor: 10.122

7.  Clinical reliability of multi-drug intracavernous vasoactive pharmacotherapy for diabetic impotence.

Authors:  F Montorsi; G Guazzoni; F Bergamaschi; M Zucconi; P Rigatti; G Pizzini; A Miani; G Pozza
Journal:  Acta Diabetol       Date:  1994-04       Impact factor: 4.280

8.  Hydroxyl fasudil, an inhibitor of Rho signaling, improves erectile function in diabetic rats: a role for neuronal ROCK.

Authors:  Sena F Sezen; Gwen Lagoda; Biljana Musicki; Arthur L Burnett
Journal:  J Sex Med       Date:  2014-06-12       Impact factor: 3.802

9.  The effect of DA-8159 on corpus cavernosal smooth muscle relaxation and penile erection in diabetic rabbits.

Authors:  Kyung Koo Kang; Seul Min Choi; Gook Jun Ahn; Jong Won Kwon; Won Bae Kim
Journal:  Urol Res       Date:  2004-03-13

Review 10.  How to treat erectile dysfunction in men with diabetes: from pathophysiology to treatment.

Authors:  Konstantinos Hatzimouratidis; Dimitrios Hatzichristou
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.